Grail

Oncology

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

News

Elderly man talks to younger female nurse beside a Grail screening vehicle

Grail's multi-cancer test fluffs its lines in UK trial

Grail's Galleri blood test for cancer screening missed the mark in the much-anticipated NHS-Galleri trial, wreaking havoc with the firm's share price.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

ESMO: Grail's data on cancer blood test firms up

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

News

Grail plans FDA filing for cancer blood test after new trial

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.

News

Illumina avoids hefty EU fine over Grail merger

The top court in the EU has ruled that the European Commission exceeded its authority in its investigation of the $8 billion merger between Illumina and Grail, albeit too late to halt the f

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

Grail's multi-cancer test fluffs its lines in UK trial

Grail multi-cancer test taps into Hims & Hers network

ESMO: Grail's data on cancer blood test firms up

Grail plans FDA filing for cancer blood test after new trial

Illumina avoids hefty EU fine over Grail merger

EMA advisors say CSL's Tavneos should be pulled from sale

Discover a new era of healthcare panel engagement: Grounded ...

Grail

Editor's Picks